Physician profile
Frank E Dalichow
NPI 1194769315
$650.79
in general payments reported to CMS, 2019-2025
8 companies · $291 in 2025
The $291 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21.56 · 2020: $25.04 · 2022: $78.02 · 2023: $48.56 · 2024: $186 · 2025: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $526.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $526.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $227.30 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $160.31 | 2024-2025 | Opdivo |
| Springworks Therapeutics, INC. | $90.00 | 2025 | Gomekli |
| Merck Sharp & Dohme LLC | $54.17 | 2022-2023 | Lynparza, Keytruda |
| Lilly USA, LLC | $39.08 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.30 | 2019-2020 | |
| Pharmacyclics LLC, An Abbvie Company | $33.33 | 2022-2023 | Imbruvica |
| Novartis Pharmaceuticals Corporation | $12.30 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Dalichow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.